Brigatinib in ALK-positive NSCLC Identified Via Blood-based Assays

Clinical trial NCT04074993 · UNKNOWN

Trial details

NCT number: NCT04074993
Sponsor: JI-YOUN HAN
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non Small Cell Lung Cancer

Start date: 2020-05-15
Primary completion: 2025-01-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.